Nsclc is an English word. Below you'll find 10+ example sentences showing how it's used in practice.
Nsclc in a sentence
Nsclc meaning
Initialism of non-small-cell lung cancer or non-small-cell lung carcinoma.
Using Nsclc
- The main meaning on this page is: Initialism of non-small-cell lung cancer or non-small-cell lung carcinoma.
- In the example corpus, nsclc often appears in combinations such as: cancer nsclc, nsclc and, nsclc patients.
Context around Nsclc
- Average sentence length in these examples: 27.4 words
- Position in the sentence: 1 start, 7 middle, 4 end
- Sentence types: 12 statements, 0 questions, 0 exclamations
Corpus analysis for Nsclc
- In this selection, "nsclc" usually appears in the middle of the sentence. The average example has 27.4 words, and this corpus slice is mostly made up of statements.
- Around the word, cancer, metastatic, lung, patients, pancreas and occurs stand out and add context to how "nsclc" is used.
- Recognizable usage signals include cell lung nsclc pancreas kidney and early stage nsclc removal of. That gives this page its own corpus information beyond isolated example sentences.
- By corpus frequency, "nsclc" sits close to words such as aaronson, abai and abass, which helps place it inside the broader word index.
Example types with nsclc
The same corpus examples are grouped by length and sentence type, making it easier to see the contexts in which the word appears:
Non-small cell lung cancer (NSCLC) is the most common type of lung cancer. (14 words)
The most common type of lung cancer, NSCLC occurs when cancer cells form in the tissues of the lung. (19 words)
This therapy targets advanced Non-Small Cell Lung Cancer (NSCLC) patients who have undergone chemotherapy and anti-PD-1 therapy. (20 words)
A total of 15 patients were evaluable for efficacy by investigator assessment, including 10 who were MET TKI-naïve: four with colorectal cancer (CRC), three with non-small cell lung cancer (NSCLC), and three with gastric or GE junction cancer (GC or GEJ). (43 words)
Up to 35% of people newly diagnosed with metastatic ROS1-positive NSCLC have tumors that have spread to their brain (brain metastases), the number increases to approximately 55% for those whose cancer has progressed following initial treatment. (37 words)
ArriVent is testing furmonertinib in a global Phase 3 clinical trial evaluating the drug as a first-line treatment for non-squamous locally advanced or metastatic NSCLC with exon 20 insertion mutations. (32 words)
Example sentences (12)
Chemotherapy before surgery in NSCLC that can be removed surgically also appears to improve outcomes. citation Chemotherapy may be combined with palliative care in the treatment of the NSCLC.
This therapy targets advanced Non-Small Cell Lung Cancer (NSCLC) patients who have undergone chemotherapy and anti-PD-1 therapy.
ArriVent is testing furmonertinib in a global Phase 3 clinical trial evaluating the drug as a first-line treatment for non-squamous locally advanced or metastatic NSCLC with exon 20 insertion mutations.
Early in the quarter Radiopharm dosed the first patient in its Phase 1 clinical trial for RAD204, a nanobody targeting PD‐L1 in patients with metastatic Non‐Small Cell Lung Cancer (NSCLC).
The study focused on patients with metastatic and advanced tumors in six common cancers: breast, colorectal, non-small cell lung (NSCLC), pancreas, kidney, and urothelial.
Up to 35% of people newly diagnosed with metastatic ROS1-positive NSCLC have tumors that have spread to their brain (brain metastases), the number increases to approximately 55% for those whose cancer has progressed following initial treatment.
A total of 15 patients were evaluable for efficacy by investigator assessment, including 10 who were MET TKI-naïve: four with colorectal cancer (CRC), three with non-small cell lung cancer (NSCLC), and three with gastric or GE junction cancer (GC or GEJ).
Non-small cell lung cancer (NSCLC) is the most common type of lung cancer.
Additionally, in a late-breaker presentation, Novartis (NVS, Not Covered) reported Phase II results from its MET inhibitor capmatinib in MET-mutated advanced non-small cell lung cancer (NSCLC) patients.
The most common type of lung cancer, NSCLC occurs when cancer cells form in the tissues of the lung.
In most cases of early-stage NSCLC, removal of a lobe of lung ( lobectomy ) is the surgical treatment of choice.
The results of this project will help scientists and doctors gain a better understanding of NSCLC and potentially lead to the development of new treatments against the disease.
Common combinations with nsclc
These word pairs occur most frequently in English texts:
- cancer nsclc 6×
- nsclc and 3×
- nsclc patients 2×
- of nsclc 2×